CROMA at ESCRS

Article

During this year?s ESCRS in Vienna CROMA will highlight its history of 35 years as a key player in ophthalmology.

During this year´s ESCRS in Vienna CROMA will highlight its history of 35 years as a key player in ophthalmology. Having started from a small pharmacy, the family-owned company reached the level of big international competitors, constantly developing innovative and unique products for markets all over the world.

Currently, CROMA is performing clinical studies, involving a new product, based on the so-called Thiomers, a unique technology combining macromolecules such as hyaluronic acid to a human amino acid (cysteine) for different ophthalmic applications. First results will be presented during the CROMA satellite symposium.

In the field of intraocular lenses, CROMA is launching two new models in 2011. The new hydrophobic blue-light filtering IOL “EYE-Cee One” has been successfully introduced in May. First clinical experiences will be shared during the ESCRS lunch symposium. CROMA will further make use of the ESCRS in Vienna to internationally launch its new multifocal IOL.

CROMA satellite symposium:

“Amazing Advances in Ocular Excellence”
Sunday, 18th September, 2011
1:00 pm – 2:00 pm
Room Stolz 1

CROMA - Bausch and Lomb joint satellite symposium:

“Bromfenac, a new potent Tool in Inflammation Control post cararact surgery”
Sunday, 18th September, 2011
1:00 pm – 2:00 pm
Room Strauss 3

Click here to register online.

Click here to email CROMA

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.